Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion evidence source_evidence_literature NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion SIO_000772 23938603 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion wasDerivedFrom befree-20140225 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion wasGeneratedBy ECO_0000203 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.